FDA let drugs approved by fraudulent research stay on market

ProPublica reports that in 2011, the U.S. Food and Drug Administration announced years' worth of studies from a major drug research lab were potentially worthless. Those studies were part of the bases for about 100 drugs that made it to the U.S. market. According to ProPublica, the FDA let those drugs stay on pharmacy shelves with no new testing and has refused to name the drugs, saying to do so would reveal trade secrets. Meanwhile, the FDA's European counterpart ordered several of the drugs to be pulled from shelves.